panaxadiol

Panaxadiol (20(R)-Panaxadiol) is a novel antitumor agent extracted from the Chinese medicinal herb Panax ginseng.

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol) (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponin.

Neopanaxadiol, an aglycone derived from protopanaxadiol type ginsenosides, exhibits promising potential for Alzheimer's disease research.

1. (20R)-Protopanaxadiol ((20R)-Protopanaxdiol) has the effect of anti-tumor through increasing the activity of body immunity, inhibiting tumor interstitial microvascular density and its proliferation activity, improving the lymphocyte transformation, the activity of NK cells and the contents of IL-2 significantly. 2. (20R)-Protopanaxadiol prevents and heals obesity, fatty liver and hypertriglyceridemia in mice fed with a high-fat diet.

(20S)-Protopanaxadiol-3-one is a natural compound isolated from Melia azedarach and Betula pendula [1].

25(R)-Hydroxyprotopanaxadiol is a natural product

20(R)-25-Methoxyprotopanaxadiol is a natural product that can be used in related research in the field of life sciences. Its product number is TN8472.

Ginsenoside Ra6 (Ginsenoside IV), a panaxadiol-type ginsenoside, is isolated from the roots of ginseng [1].